Dr. Martins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
VCU Health at Stony Point 9000
9000 Stony Point Pkwy
Richmond, VA 23235Phone+1 804-327-3055
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1995 - 1998
Gundersen Lutheran Medical FoundationResidency, Internal Medicine, 1993 - 1995
Steward Carney HospitalInternship, Internal Medicine, 1992 - 1993
Faculdade de Medicina da Universidade Federal do Rio de JaneiroClass of 1992
Certifications & Licensure
VA State Medical License 2022 - 2026
WA State Medical License 2003 - 2023
WI State Medical License 1994 - 1995- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
Clinical Trials
- Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer Start of enrollment: 2005 Jul 01
- Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2006 Feb 01
- Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer Start of enrollment: 2006 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 5868 citationsSafety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerJulie R. Brahmer, Scott S. Tykodi, Laura Q.M. Chow, Wen-Jen Hwu, Suzanne L. Topalian
The New England Journal of Medicine. 2012-06-28 - 1052 citationsCarboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-...Corey J. Langer, Shirish M. Gadgeel, Hossein Borghaei, Vassiliki A. Papadimitrakopoulou, Amita Patnaik
The Lancet. Oncology. 2016-11-01 - 270 citationsPhase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functiona...Laurie L. Carr, David A. Mankoff, Bernardo H. L. Goulart, Keith D. Eaton, Peter T. Capell
Clinical Cancer Research. 2010-11-01
Other
- Systemic treatment of advanced cutaneous squamous and basal cell carcinomasMartins RG
http://www.uptodate.com/contents/systemic-treatment-of-advanced-cutaneous-squamous-and-basal-cell-ca
UpToDate, Wolters Kluwer Health - 2012-06-15
Press Mentions
Renato Martins, MD, MPH on Germline Testing in Lung CancerNovember 25th, 2022- Study Shows High Rate of Actionable Mutations in Lung Cancer -News ForestAugust 17th, 2022
- Study Shows Germline Testing May Be Warranted for All Patients With Lung CancerAugust 17th, 2022
- Join now to see all
Other Languages
- Spanish, Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
